Evidence map›Paper›PMID 34833905›Full record

ArticleMolecules (Basel, Switzerland)2021

Novel Triterpenoids from

Sabapathy Indu, Periyasamy Vijayalakshmi, Jayaraman Selvaraj, Manikkam Rajalakshmi

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Nutrients · 2023
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sabapathy InduDBT-BIF Centre, PG & Research Department of Biotechnology & Bioinformatics, Holy Cross College (Autonomous), Bharathidasan University, Trichy 620002, Tamil Nadu, India.
Periyasamy VijayalakshmiDBT-BIF Centre, PG & Research Department of Biotechnology & Bioinformatics, Holy Cross College (Autonomous), Bharathidasan University, Trichy 620002, Tamil Nadu, India.
Jayaraman SelvarajDepartment of Biochemistry, Saveetha Institute of Medical and Technical Sciences, Saveetha Dental College and Hospitals, Saveetha University, Chennai 600020, Tamil Nadu, India.ORCID 0000-0002-7726-1423
Manikkam RajalakshmiDBT-BIF Centre, PG & Research Department of Biotechnology & Bioinformatics, Holy Cross College (Autonomous), Bharathidasan University, Trichy 620002, Tamil Nadu, India.
Bharathidasan University · INSaveetha University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we identified the mechanisms of action of antidiabetic activity of novel compounds isolated from

Indexed as

AnimalsBlood GlucoseCassiaC-PeptideDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1GlucokinaseGlucose-6-PhosphataseHypoglycemic AgentsInsulinInsulin Receptor Substrate ProteinsLipid MetabolismMaleMolecular Docking SimulationMolecular StructureMuscle, SkeletalBlood GlucoseC-PeptideGlucokinaseGlucose-6-PhosphataseHypoglycemic AgentsInsulinInsulin Receptor Substrate ProteinsIrs1 protein, ratPotassium Channels, Inwardly RectifyingPPAR gammaProto-Oncogene Proteins c-aktRNA, MessengerTriterpenesCassia fistuladiabetes mellitusin silicoinsulin signalingin vivonovel triterpenoids

Identifiers

PMID34833905
PMCPMC8621110
OpenAlexW3212421522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.